Concerning Ruminiclostridium 9, it has demonstrated its regulatory effects on lipid metabolism, inflammation reduction, enhancement of intestinal barrier function, weight gain reduction, and improved insulin sensitivity in mice, effectively countering obesity development [48]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.